Clinical Trial Update: Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial update on belimumab for active lupus nephritis reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Lupus Nephritis | Phase 3 | Status: COMPLETED | Results posted: 2020-07-07